Ventas Cambio Fecha
Adma Biologics USD 124.4M 9.9M 2026-06
Agenus USD 33.7M 500K 2026-03
AstraZeneca USD 16.21B 830M 2026-09
BioCryst Pharmaceuticals USD 218.25M 188.3M 2026-06
Geron USD 60.19M 2.71M 2026-09
GlaxoSmithKline GBP 8.89B 480M 2026-09
MannKind USD 101.9M 7.47M 2026-09
Merck USD 18.1B 1.5B 2026-09
Minerva Neurosciences USD 0 0 2024-09
Moderna USD 1.31M 98.69M 2026-09
Novartis USD 15.03B 1.92B 2026-09
Novavax USD 147.14M 76.69M 2025-12
Pfizer USD 16.6B 1.57B 2026-09
Sanofi EUR 14.44B 2.49B 2026-09
Sarepta Therapeutics USD 381.4M 19.9M 2026-09
TG Therapeutics USD 259.94M 19.6M 2026-09